Cancer combo trial halted early: did the STING drug fall short?
NCT ID NCT05846659
First seen May 17, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This study tested whether adding an experimental drug called IMSA101 to a combination of targeted radiation and immunotherapy could help control cancers that were slowly progressing despite prior treatment. The trial enrolled 16 adults with various solid tumors that had up to 6 growing spots. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOPROGRESSIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine Medical Center
Houston, Texas, 77030, United States
-
Brigham and Women's Hospital/Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California, 92618, United States
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, 10016, United States
-
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, 44106, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
UCLA
Los Angeles, California, 90095, United States
-
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.